A critical role for thrombin in platelet aggregation under high shear stress

Thrombosis Research

Volumn 113, Issue 5, 2004, Pages 311-318

  Sakurai, Yoshihiko ^a   Shima, Midori ^a   Giddings, John ^b   Takeyama, Masahiro ^a   Kasuda, Shogo ^a   Nogami, Keiji ^a   Nishiya, Katsumi ^a   Yoshioka, Akira ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AhT; Anhydrothrombin; anhydrothrombin; Antithrombotic; CFT; clot formation time; clotting time; Coagulation; CT; FFP; formalin fixed platelets; MCF; Platelet aggregation; platelet poor plasma; platelet rich plasma; PPP; PRP; Shear; washed platelets; WP

Indexed keywords

ANHYDROTHROMBIN; ANTICOAGULANT AGENT; THROMBIN; THROMBIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CATALYSIS; FIBRIN CLOT; HUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SHEAR STRESS; THROMBOCYTE AGGREGATION;

ANTICOAGULANTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTHROMBIN TIME; STRESS, MECHANICAL; THROMBELASTOGRAPHY; THROMBIN; VON WILLEBRAND FACTOR;

EID: 2942627502     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.03.015     Document Type: Article

References (30)

1. Hoffman M., Monroe D.M. III A cell-based model of hemostasis. Thromb. Haemost. 85:2001;958-965
2. Berndt M.C., Gregory C., Dowden G., Castaldi P.A. Thrombin interactions with platelet membrane proteins. Ann. N. Y. Acad. Sci. 485:1986;374-386
3. Fuster V., Steele P.M., Chesebro J.H. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J. Am. Coll. Cardiol. 5:1985;175B-184B
4. Adam F., Bouton M.C., Huisse M.G., Jandrot-Perrus M. Thrombin interaction with platelet membrane glycoprotein Ib alpha. Trends Mol. Med. 9:2003;461-464
5. Kahn M.L., Nakanishi-Matsui M., Shapiro M.J., Ishihara H., Coughlin S.R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103:1999;879-887
6. Covic L., Gresser A.L., Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry. 39:2000;5458-5467
7. Shattil S.J. Signaling through platelet integrin αIIbβ3: inside-out, outside-in, and sideways. Thromb. Haemost. 82:1999;318-325
8. Hanson S.R., Harker L.A. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc. Natl. Acad. Sci. U. S. A. 85:1988;3184-3188
9. Jang I.K., Gold H.K., Ziskind A.A., Leinbach R.C., Fallon J.T., Collen D. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation. 81:1990;219-225
10. Talbot M.D., Ambler J., Butler K.D., Lees C.M., Mitchell K.A., Peters R.F., et al. The effects of recombinant desulphatohirudin on arterial thrombosis in rats. Haemostasis. 21(Suppl. 1):1991;73-79
11. Nunes G.L., Hanson S.R., King S.B. III, Sahatjian R.A., Scott N.A. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J. Am. Coll. Cardiol. 23:1994;1578-1583
12. Gast A., Tschopp T.B., Baumgartner H.R. Thrombin plays a key role in late platelet thrombus growth and/or stability. Effect of a specific thrombin inhibitor on thrombogenesis induced by aortic subendothelium exposed to flowing rabbit blood. Arterioscler. Thromb. 14:1994;1466-1474
13. Scott N.A., Nunes G.L., King S.B. III, Harker L.A., Hanson S.R. Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation. 90:1994;1951-1955
14. Meyer B.J., Badimon J.J., Mailhac A., Fernandez-Ortiz A., Chesebro J.H., Fuster V., et al. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. Circulation. 90:1994;2432-2438
15. Li W.X., Kaplan A.V., Grant G.W., Toole J.J., Leung L.L. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation. Blood. 83:1994;677-682
16. Ashton R.W., Scheraga H.A. Preparation and characterization of anhydrothrombin. Biochemistry. 34:1995;6454-6463
17. Hosokawa K., Ohnishi T., Shima M., Nagata M., Koide T. Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates. Biochem. J. 354:2001;309-313
18. Nogami K., Shima M., Hosokawa K., Nagata M., Koide T., Saenko E.L., et al. Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689. J. Biol. Chem. 275:2000;25774-25780
19. Lees S.J., Macartney N.J., Hathaway L.S., Giddings J.C., Dasani H., Collins P.W. Antibody to human thrombin following treatment with fibrin sealant of bovine origin [abstract]. Thromb. Haemost. 86(Suppl. 1):2001;2880
20. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y., et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87:1991;1234-1240
21. Jandrot-Perrus M., Bouton M.C., Lanza F., Guillin M.C. Thrombin interaction with platelet membrane glycoprotein Ib. Thrombin interaction with platelet membrane glycoprotein Ib. Semin. Thromb. Hemost. 22:1996;151-156
22. Calatzis A., Haas S., Gödje O., Calatzis A., Hipp R., Walenga J. Thromboelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer. Pifarre R. Management of bleeding in cardiovascular surgery. 2000;215-226 Hanley & Belfus, Philadelphia, PA
23. Khurana S., Mattson J.C., Westley S., O'Neill W.W., Timmis G.C., Safian R.D. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J. Lab. Clin. Med. 130:1997;401-411
24. Goto S., Ikeda Y., Saldivar E., Ruggeri Z.M. Distinct mechanism of platelet aggregation as a consequence of different shearing flow conditions. J. Clin. Invest. 101:1998;479-486
25. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:1996;3456-3464
26. Chow T.W., Hellums J.D., Thiagarajan P. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J. Lab. Clin. Med. 135:2000;66-72
27. Dörmann D., Clemetson K.J., Kehrel B.E. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood. 96:2000;2469-2478
28. Ramakrishnan V., DeGuzman F., Bao M., Hall S.W., Leung L.L., Phillips D.R. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1823-1828
29. Soslau G., Class R., Morgan D.A., Foster C., Lord S.T., Marchese P., et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J. Biol. Chem. 276:2001;21173-21183
30. Dicker I.B., Pedicord D.L., Seiffert D.A., Jamieson G.A., Greco N.J. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Thromb. Haemost. 86:2001;1065-1069